Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
THL Partners Acquires Headlands Research
On August 14, THL Partners announced that it acquired Headlands Research from KKR & Co. Headlands Research is a globally integrated clinical trial site organization. With a multinational network of 21 clinical trial sites, Headlands Research has successfully completed more than 5,000 clinical trials. It is based in San Francisco, California. THL Partners is a private equity firm investing in middle-market growth companies exclusively within three sectors: healthcare, financial technology & services and technology & business solutions. Since 1974, THL has raised more than $35 billion of equity capital, invested in upwards of 170 companies and completed more than 600... Read More »
Navigating the Occupational Health M&A Market: From Record Highs to a Measured Pace
Occupational health, not to be confused with occupational therapy, focuses on ensuring workplace safety, employee wellness and compliance with health regulations. Occupational health provides employer-driven services, such as injury prevention, health screenings and compliance programs, and is vital for workforce productivity and risk management. In recent years, the sector has seen a dramatic shift in merger and acquisition (M&A) activity, with 2025 marking a significant slowdown in the space. A Marked Decline in 2025 Deal Activity According to data captured by LevinPro HC, there have been six occupational health transactions announced year-to-date (as of August 11, 2025).... Read More »
Nucleus Network Acquires Hammersmith Medicines Research
On August 4, Nucleus Network announced the acquisition of Hammersmith Medicines Research (HMR) for an undisclosed price. HMR specializes in early clinical trials for pharmaceutical and biotechnology companies worldwide. Founded in 1993, HMR is now the biggest contract research organization (CRO) of its kind in the United Kingdom and one of the biggest in Europe. Melbourne-based Nucleus Network is the only early-phase clinical research provider with a global footprint, operating dedicated Phase I facilities in Australia, the United States and the United Kingdom. “We are deeply honored by the trust Dr Boyce has placed in us to carry forward HMR’s legacy,” said Teena Pisarev, Chief Executive... Read More »
Generational Group Advises Excel Pediatric Therapy in its Sale to an Individual Investor
Generational Group announced on July 29 the sale of The Rockwall Center of Sensory Integration, Inc., doing business as Excel Pediatric Therapy, to an undisclosed individual investor. The acquisition closed June 27, 2025. Financial terms were not disclosed. Excel Pediatric Therapy offers comprehensive physical, occupational and speech therapy for children from birth up to seventeen years old. Based in Rockwall, Texas, the clinic treats a range of neurological, orthopedic and developmental conditions, such as sensory processing disorders, autism, ADHD, cerebral palsy and feeding issues. Generational Group is a leading mergers and acquisitions advisory firm for privately held businesses. It... Read More »
LucyRx Acquires CerpassRx in First PBM Deal of 2025
According to a July 31 announcement, LucyRx has signed a definitive agreement to bring CerpassRx under its umbrella. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025. CerpassRx is a leading, full-service, pharmacy benefit manager (PBM) based in the Dallas-Fort Worth, Texas area. Its services include prescription optimization, flexible formulary designs, personalized member support and mail and specialty pharmacy programs. CerpassRx is a division of Nomi Health, a direct healthcare company. LucyRx is a PBM known for simplifying and improving access to prescription care. Partnering with more than 60,000 pharmacies, LucyRx... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
